Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and guaifenesin

tobramycin has been researched along with guaifenesin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (66.67)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Cavallaro, G; Craparo, EF; Cusimano, MG; Giammona, G; Porsio, B; Schillaci, D; Spigolon, D1
Bahamondez-Canas, TF; Leal, J; Smyth, HDC; Tewes, F; Zhang, H1
Börger, C; Braun, A; Häussler, S; Hittinger, M; Lehr, CM; Müller, L; Murgia, X; Schwarzkopf, K; Sewald, K; Siebenbürger, L; Wronski, S1
Arnold, K; Ernst, J; Fischer, D; Hartung, A; Klinger-Strobel, M; Makarewicz, O; Pletz, MW; Thamm, J1
Ascenzioni, F; Cavallaro, G; De Rocco, D; Di Domenico, EG; Giammona, G; Porsio, B; Santucci, R; Sardo, C1
Elgaher, WAM; Haupenthal, J; Hirsch, AKH; Lababidi, N; Ofosu Kissi, E; Rades, T; Schneider, M; Schwarz, BC; Sigal, V1
Andreas, A; Christmann, R; Couvreur, P; De Rossi, C; Desmaele, D; Empting, M; Hartmann, RW; Herrmann, J; Ho, DK; Hüfner de Mello Martins, AG; Koch, M; Lehr, CM; Loretz, B; Müller, R; Murgia, X1
de Souza Carvalho-Wodarz, C; Lababidi, N; Lehr, CM; Montefusco-Pereira, CV; Schneider, M1
Boese, A; de Souza Carvalho-Wodarz, C; Frisch, S; Ho, DK; Horstmann, JC; Huck, B; Lehr, CM; Loretz, B; Murgia, X; Schwarzkopf, K1

Other Studies

9 other study(ies) available for tobramycin and guaifenesin

ArticleYear
Polyanion-tobramycin nanocomplexes into functional microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
    Nanomedicine (London, England), 2017, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Drug Carriers; Drug Liberation; Epithelial Cells; Humans; Mannitol; Mucus; Nanocomposites; Polyelectrolytes; Polymers; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2017
PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Molecular pharmaceutics, 2018, 04-02, Volume: 15, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Chickens; Cystic Fibrosis; Humans; Lung; Microbial Sensitivity Tests; Mucus; Polyethylene Glycols; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Swine; Tobramycin

2018
Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.
    The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10

    Topics: Anti-Bacterial Agents; Biofilms; Colistin; Humans; Microbial Sensitivity Tests; Mucus; Pseudomonas aeruginosa; Tobramycin; Trachea

2018
Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2018, Volume: 131

    Topics: Anti-Bacterial Agents; Biofilms; Burkholderia cepacia complex; Cystic Fibrosis; Drug Carriers; Humans; Lung; Materials Testing; Microbial Sensitivity Tests; Mucus; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Pseudomonas aeruginosa; Tobramycin

2018
Nanometric ion pair complexes of tobramycin forming microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
    International journal of pharmaceutics, 2019, May-30, Volume: 563

    Topics: Anti-Bacterial Agents; Biofilms; Cell Line; Cystic Fibrosis; Drug Carriers; Humans; Mucus; Nanoparticles; Peptides; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2019
Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 11-28, Volume: 314

    Topics: Acetylcysteine; Administration, Inhalation; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Cystic Fibrosis; Drug Stability; Drug Storage; Expectorants; Horses; Mucus; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2019
Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections.
    Angewandte Chemie (International ed. in English), 2020, 06-22, Volume: 59, Issue:26

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Delayed-Action Preparations; Drug Synergism; Humans; Microbial Sensitivity Tests; Mucus; Nanoparticles; Pseudomonas aeruginosa; Quinolones; Quorum Sensing; Squalene; Sulfuric Acid Esters; Tobramycin; Zebrafish

2020
Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2020, Volume: 157

    Topics: Acetylcysteine; Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Ciprofloxacin; Curcumin; Cytokines; Drug Carriers; Drug Combinations; Drug Compounding; Expectorants; Freeze Drying; Humans; Inflammation Mediators; Macrophages; Microbial Viability; Mucus; Nanoparticles; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; THP-1 Cells; Tobramycin

2020
A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms.
    The Journal of antimicrobial chemotherapy, 2021, 05-12, Volume: 76, Issue:6

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Mucus; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2021